JPH01294657A - Novel amide compound and production thereof - Google Patents

Novel amide compound and production thereof

Info

Publication number
JPH01294657A
JPH01294657A JP62329012A JP32901287A JPH01294657A JP H01294657 A JPH01294657 A JP H01294657A JP 62329012 A JP62329012 A JP 62329012A JP 32901287 A JP32901287 A JP 32901287A JP H01294657 A JPH01294657 A JP H01294657A
Authority
JP
Japan
Prior art keywords
compound
zanthoxylum
amide compound
water
extraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62329012A
Other languages
Japanese (ja)
Inventor
Osamu Tanaka
治 田中
Toru Fuwa
不破 亨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Priority to JP62329012A priority Critical patent/JPH01294657A/en
Publication of JPH01294657A publication Critical patent/JPH01294657A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NEW MATERIAL:An amide compound expressed by the formula. USE:An anesthetic agent, capable of exhibiting rapid and prolonged paralytic and anesthetic effects and useful for relieving pains, anesthetization in operation, etc. PREPARATION:An optional part, preferably pericarp part of a plant (e.9., Zanthoxylum bungeanum Maxim. or Zanthoxylum periperitum De Candolle) belonging to the genus Zanthoxylum of the family Rutaceae is dried or used in the state and directly extracted. The extraction is carried out by using water or an organic solvent (e.g., chloroform) at <=40 deg.C for 20-40 hr by stirring, shaking, etc. The resultant extract, as necessary, is concentrated at a low temperature under reduced pressure or freeze-dried and subsequently purified by chromatography to afford the aimed substance.

Description

【発明の詳細な説明】 [発明の背景] 致亙立… 本発明は、サンシiつ属(Zanthoxylum) 
@物より得られた新規アミド化合物及びその製造法に関
する。さらに具体的には、サンショウ属植物に属する花
l(Zanthoxylum bunBeanum M
axim、)より得られた新規アミド化合物及びその製
造法に関するものである。
[Detailed Description of the Invention] [Background of the Invention] Development of the present invention...
This article relates to a new amide compound obtained from @mono and its manufacturing method. More specifically, Zanthoxylum bunBeanum M
axim, ) and a method for producing the same.

洗JuE肛 サンショウ属(Zanthoxylum)植物に属する
花標(Zanthoxylun+ bungeanum
 Maxim、)は、高さ3〜61fiの低木あるいは
小高木であって、中国では大部分の地域に分布する0日
本産の花様は、実際にはサンショウ(Zanthoxy
lum piperitum De Candolle
 )であって、中国では産生じない〔上海科学技術出版
社編「中薬大辞典」、第1巻第279〜282頁((株
)小学館発行(1985年12月10日))〕。この花
淑およびその他同属植物は、相、葉、種子、茎、果皮、
外皮等あらゆる部分が薬理となり得て、種々の薬理作用
が知られている(例えば、消化不良、下痢、筋痛、歯痛
、回虫症などの薬効が確認されている)。
Zanthoxylum+ bungeanum
Maxim, ) is a shrub or small tree with a height of 3 to 61 fi, distributed in most areas in China.
lum piperitum De Candolle
) and is not produced in China [Compiled by Shanghai Science and Technology Publishing Company, "Dictionary of Chinese Medicine," Volume 1, pp. 279-282 (published by Shogakukan Co., Ltd. (December 10, 1985))]. This Hanashuku and other congeners are divided into phases, leaves, seeds, stems, pericarp,
All parts, including the outer skin, can be medicinal, and various pharmacological actions are known (for example, medicinal effects have been confirmed for indigestion, diarrhea, myalgia, toothache, ascariasis, etc.).

ところで、花様中には、ゲラニオール、リモネン、クミ
ンアルコール、ステロールまたはエストラゴール、ベル
ガブテンまたは安息香酸類などの微量成分が確認されて
いる〔上海科学技術出版社編「中薬大辞典お第1巻第2
79〜282頁((株)小学館発行(1985年!2月
10日))〕。また辛味成分としては山標(Zanth
oxylum bungeanum Maxim、)と
同様、α−サンショール、ヒドロキシ−α−サンショー
ル、β−サンショール、ヒドロキシ−β−サンショール
、γ−サンシミール、ヒドロキシ−γ−サンショールの
存在も確認されている( J、Chem、Soc、、2
760(1957)、Phytochemistry、
21.1295(1982))。
By the way, trace components such as geraniol, limonene, cumin alcohol, sterol or estragol, bergabuten or benzoic acids have been confirmed in the flower [Compiled by Shanghai Science and Technology Publishing House, "Dictionary of Traditional Chinese Medicine, Vol. 1"] 2
Pages 79-282 (published by Shogakukan Co., Ltd. (February 10, 1985))]. Also, the spiciness component is Zanth.
oxylum bungeanum Maxim,), the presence of α-sanshool, hydroxy-α-sanshool, β-sanshhol, hydroxy-β-sanshool, γ-sansimil, and hydroxy-γ-sanshhol has also been confirmed ( J,Chem,Soc,,2
760 (1957), Phytochemistry,
21.1295 (1982)).

[発明の概要] 1−旦 本発明は、サンショウ属植物の成分に関して鋭意研究を
行なった結果、抽出画分、特に花峨由釆の抽出画分に新
規アミド化合物があったという発見に基づくものである
[Summary of the Invention] 1-Dan The present invention is based on the discovery that a novel amide compound was found in the extracted fraction, especially the extracted fraction of Hanaga Yuba, as a result of intensive research on the components of plants of the genus Salmonella. It is something.

従って、本発明によるアミド化合物は、下式(1)で示
されること、を特徴とするものである。
Therefore, the amide compound according to the present invention is characterized by being represented by the following formula (1).

CH3CH2CH=CHCH2CH=CH−CH2CH
2CH=CHCH=CHCONIi−CH2C(CH3
)2OH また前記式(1)で示されるアミド化合物の製造法は、
サンショウg(Zanthoxy lum)植物より取
得すること、を特徴とするものである。
CH3CH2CH=CHCH2CH=CH-CH2CH
2CH=CHCH=CHCONIi-CH2C(CH3
)2OH Furthermore, the method for producing the amide compound represented by the above formula (1) is as follows:
It is characterized in that it is obtained from the Zanthoxy lum plant.

羞呆 本発明は、サンショウ属(Zanthoxy lum)
植物に新規アミド化合物があったということは思いがけ
なかったことというべく、そして本発明によるアミド化
合物は麻酔作用を有することより、麻酔剤の提供は言う
までもなく諸疾患対策に有意義な貢献をなすものである
The present invention relates to Zanthoxylum spp.
The discovery of a new amide compound in plants was unexpected, and since the amide compound of the present invention has an anesthetic effect, it will not only provide an anesthetic, but will also make a meaningful contribution to countering various diseases. be.

[発明の詳細な説明] ヱまヱ■立腹 本発明によるアミド化合物は、前記式(1)で示される
化合物である。この化合物は、分子内に4つの二重結合
を有するため、種々の幾何異性体が 1存在するが、本
発明ではいずれをも含むものである。これらの化合物の
うち、−具体例について示せば、下記の通りである。
[Detailed Description of the Invention] The amide compound according to the present invention is a compound represented by the above formula (1). Since this compound has four double bonds in its molecule, it has one variety of geometric isomers, and the present invention includes all of them. Among these compounds, specific examples are as follows.

化合物■ 性状:淡黄色油状物質、刺激性 (Z)   (Z)     (E)  (E)CH3
CH2CH=CHCH2CH=CH−Cl12CH2C
H=CHCH=CH(CONH−CH2C(CH3)2
OH 化合物II 性状:淡黄色油状物質、刺激性 (E)   (Z)     (E)  (E)CH3
CH2CH=CHCH2CH=CH−CH2CH2CH
=CHCH=CHCONH−CH2C(CH3)2OH 〔なお、式中の(E)、(Z)は立体異性を示す。]サ
ンショウ Zanthox Ium)  物本発明でい
うサンショウ属(Zanthoxylum)植物は、ミ
カン科すンショウ属に属する植物であればよく、例えば
花[(Zanthoxylum bun8eanumM
axim、)、山l(Zanthoxylum pip
eritum CD)、冬山JZanthoxylum
 planispinum 5ieb、et Zucc
、]、鳥の山[(Zanthoxylum ailan
thoides 5ieb、 etZucc、 )、犬
山1fi(Zanthoxylum schinifo
lium 5ieb。
Compound ■ Properties: Pale yellow oily substance, irritating (Z) (Z) (E) (E) CH3
CH2CH=CHCH2CH=CH-Cl12CH2C
H=CHCH=CH(CONH-CH2C(CH3)2
OH Compound II Properties: Pale yellow oily substance, irritating (E) (Z) (E) (E) CH3
CH2CH=CHCH2CH=CH-CH2CH2CH
=CHCH=CHCONH-CH2C(CH3)2OH [In the formula, (E) and (Z) indicate stereoisomerism. ] Plants of the genus Zanthox as used in the present invention may be plants belonging to the genus Zanthox of the Rutaceae family, such as flowers [(Zanthoxylum bun8eanumM
axim, ), Zanthoxylum pip
eritum CD), Fuyuyama JZanthoxylum
planispinum 5ieb, et Zucc
, ], Bird Mountain [(Zanthoxylum ailan
thoides 5ieb, etZucc, ), Inuyama 1fi (Zanthoxylum schinifo
lium 5ieb.

et Zucc、)など(誠文堂新光社発行伊沢凡人著
r原色版日本薬用植物辞典j p238〜243(19
81年4月15日発行)、及び前掲書、第−巻、第27
9〜282参照)任意のものを用いることができる。こ
れらのうちの好ましい具体例は、後記実施例に示すよう
に花閲である。
et Zucc, ) etc. (published by Seibundo Shinkosha, written by Bonjin Izawa, primary color version Japanese Medicinal Plant Dictionary j, p. 238-243 (19
(Published on April 15, 1981), and the above-mentioned book, Volume - No. 27
(Refer to 9-282) Any one can be used. Among these, a preferred specific example is Hanaku, as shown in Examples below.

花閲は中国全土に分布する低木あるいは小高木(高さ3
〜6m)植物で、開花期が3〜5月、結実期が7〜10
月で、果実は赤色ないし紫赤色で一面にこぶし状に突起
した線点がみられ、中の種子は1個で黒色を呈している
。孔開の異名としては、ダイショウ(大間)、シンショ
ウ(秦淑)、ショクショウ(蜀繊、テンショウ(南標)
、ハシヨウ(6櫂、カンショウ(漢標)、センショウ(
用標)あるいはテンショウ(点標)等がある(前掲生薬
大辞典)が、本発明における孔開はこれらの異名を総称
するものとする。
Flowering plant is a shrub or small tree (height 3
~6m) plant, flowering period is March to May, fruiting period is July to October
The fruit is red or purplish-red and has fist-shaped dots all over it, and the single seed inside is black. Other names for Kong Kai include Daisho (Oma), Shinsho (Qin Shu), Shokusho (Shusen), and Tensho (Nanbeo).
, Hashiyou (6 paddles, Kansho (Chinese mark), Sensho (
There are many other names such as ``symbol'' or ``dot marker'' (see the above-mentioned Dictionary of Crude Drugs), but in the present invention, the term ``hole-open'' refers to these synonyms collectively.

アミド化  の 得 サンショウ属植物からアミド化合物の取得は、基本的に
は植物生薬の抽出および精製に慣用される任意の手段に
より行なうことができる。
Obtaining amidation An amide compound can be obtained from a plant of the genus Salmonella by any means commonly used for the extraction and purification of herbal medicines.

まず、抽出対象はサンショウ属植物体の任意の部分であ
りうるが、とりわけ果皮部分が好ましい。
First, the target for extraction may be any part of a plant of the genus Salmonella, but the pericarp is particularly preferred.

採取したものは、乾燥するかそのままの状態で用いるこ
とができる。また、薬剤となり得る植物部分を適宜粉砕
すれば抽出効率があがることは言うまでもない、以下抽
出および精製について具体的に説明する。
The collected material can be dried or used as is. Furthermore, it goes without saying that extraction efficiency can be increased by appropriately crushing plant parts that can be used as medicines.Extraction and purification will be specifically explained below.

イ)抽出 本発明でいう抽出工程は基本的には植物生薬の抽出に慣
用される任意の手段により行なうことができる。例えば
、上記花閲またはその他同属植物薬理を水または含水、
非含水の有機溶媒を用いて抽出を行なうことができる。
B) Extraction The extraction step referred to in the present invention can basically be carried out by any means commonly used for extracting botanical herbal medicines. For example, water or water-containing,
Extraction can be carried out using water-free organic solvents.

抽出は、加温下、常温下あるいは低温下で1回ないし複
数回行なうことができるが、常温下あるいは低温下では
抽出時間が長く、数十分から数日程度が必要であること
が普通である。好ましくは、40°C以下で20時間か
ら40時間抽出に付すのがよい。また、抽出効率を上げ
るため、撹拌または振盪などの操作を行うことがあるこ
とはいうまでもない。抽剤は水または含水、非含水の任
意の有機溶媒であるが、好ましくは水あるいは含水、非
含水の低級アルコール(炭素数1〜4の1価アルコール
が普通である)または水と分配可能な有機溶媒を用いる
ことができる。
Extraction can be carried out once or multiple times under heating, room temperature, or low temperature; however, extraction time at room temperature or low temperature is usually long, ranging from several tens of minutes to several days. be. Preferably, the extraction is carried out at 40°C or below for 20 to 40 hours. Furthermore, it goes without saying that operations such as stirring or shaking may be performed in order to increase extraction efficiency. The extractant is water or any organic solvent containing water or water-free, preferably water or a lower alcohol containing water or water-free (usually a monohydric alcohol having 1 to 4 carbon atoms) or a water-distributable organic solvent. Organic solvents can be used.

ここでいう水と分配可能な有機溶媒とは、水と互いに全
く、あるいは殆ど混じり合わない任意の有機溶媒をいい
、例えばクロロホルム、ジクロロメタン、酢酸エチル、
ベンゼン、エーテル、石油エーテル、ヘキサン、ブタノ
ールなどを例示することができる。
The term "organic solvent that can be distributed with water" as used herein refers to any organic solvent that is completely or almost immiscible with water, such as chloroform, dichloromethane, ethyl acetate,
Examples include benzene, ether, petroleum ether, hexane, and butanol.

このようにして得られた抽出画分は、必要に応じて低温
で減圧濃縮するか、または凍結乾燥に付して目的とする
画分を得ることができる。
The extracted fraction thus obtained can be concentrated under reduced pressure at low temperature or freeze-dried to obtain the desired fraction, if necessary.

口)精製 上記イ)で得られた抽出画は、順相および逆相クロマト
グラフィーを適宜組合せることにより、目的画分を得る
ことができる。組合せる順序はどちらでもよいが、好ま
しくは後記実験例に示した様に、順相クロマトグラフィ
ー次いで逆相クロマトグラフィーの順で少なくとも1回
づつ行うのがよい。
(1) Purification The target fraction can be obtained from the extracted fraction obtained in (a) above by appropriately combining normal phase and reversed phase chromatography. Although the order of combination may be either, it is preferable to perform normal phase chromatography and then reverse phase chromatography at least once, as shown in the experimental examples below.

ここでいつ順相クロマトグラフィーは、ケイ酸、シリカ
ゲル等の極性の大きい樹脂を固相担体に用いたカラムク
ロマトグラフィーをいい、移動相としては通常、クロロ
ホルム、ジクロロメタン、ヘキサンあるいは酢酸エチル
などの非極性溶媒と含水または非含水の低級アルコール
との混合液などの固相担体に比べて極性の小さい溶媒を
用いることができる。なお、上記方法の一興体例として
は、後記実施例に示すように、シリカゲルカラムクロマ
トグラフィー[展開溶媒:クロロホルム−メタノール(
30:1)あるいはベンゼン−アセトン(17:3)]
を用いて精製することができる。
Here, normal phase chromatography refers to column chromatography using a highly polar resin such as silicic acid or silica gel as a solid phase carrier, and the mobile phase is usually a nonpolar one such as chloroform, dichloromethane, hexane, or ethyl acetate. A solvent having less polarity than the solid phase support can be used, such as a mixture of a solvent and a water-containing or non-water-containing lower alcohol. An example of the above method is silica gel column chromatography [developing solvent: chloroform-methanol (
30:1) or benzene-acetone (17:3)]
It can be purified using

一方、逆相クロマトグラフィーとは、上記シリカゲルな
どに、ジメチルシラン、オクタデシルシラン、オクチル
デシルシランなどの炭素数1〜18の炭化水素残基を持
つシランを化学結合させたものや、スチレン−ジビニル
ベンゼン系共重合体あるいはゲル濾過剤など、極性の小
さい樹脂な固相担体に用いたカラムクロマトクラフィー
をいい、移動相としては上記固相担体より極性の大きい
任意の溶媒を用いることができる。例えば、含水または
非含水の低級アルコール[炭素数1〜3のもの(通常は
1価アルコール)]、あるいはアセトン、アセトニトリ
ルなどの水と混合可能な有機溶媒と水との混合液などが
使用できる。好ましい具体例としては、後記実験例に示
したようにオクタデシルシランを固相担体とし、含水ア
セトニトリルを展開溶媒として用いることができる。
On the other hand, reversed phase chromatography refers to silanes such as the above silica gel chemically bonded with silanes having hydrocarbon residues having 1 to 18 carbon atoms, such as dimethylsilane, octadecylsilane, and octyldecylsilane, or styrene-divinylbenzene. This refers to column chromatography using a resinous solid phase carrier with low polarity, such as a copolymer or a gel filtration agent, and any solvent having a higher polarity than the solid phase carrier can be used as the mobile phase. For example, water-containing or water-free lower alcohols [those having 1 to 3 carbon atoms (usually monohydric alcohols)], or mixtures of water and organic solvents that are miscible with water, such as acetone and acetonitrile, can be used. As a preferred specific example, octadecylsilane can be used as a solid phase carrier and hydrous acetonitrile can be used as a developing solvent, as shown in the experimental examples below.

農崖二爪最羞呈 本発明におけるアミド化合物は、後記実験例に示したよ
うに、即効的でかつ持続的な麻痺、麻酔効果を有するも
のである。
The amide compound in the present invention has immediate and long-lasting paralyzing and anesthetic effects, as shown in the experimental examples below.

従って、本効果は痛みの軽減、手術時の麻酔など、総合
的な治療分野に及ぶものである。
Therefore, this effect extends to comprehensive therapeutic fields such as pain relief and anesthesia during surgery.

栗鼠 本発明のアミド化合物それ自体または適宜製剤上の賦形
剤、結合剤、希釈剤と混合して成るものであり、軟膏、
クリーム、液剤、カプセル剤、シロップ剤、注射剤など
の形態で経口的または非経口的に投与することができる
。必要に応じて他の薬剤を調合させてもよい。投与量は
、年齢、体重、症状により適宜増減するが、例えば、歯
痛用口腔組成物(調製方法は特願昭61−190222
号公報参照のこと)としては通常成人、1日、アミド化
合物(オイル状としたもの)として0−1mg〜10g
程度であり、さらに好ましくは0 、5 mg〜5g程
度である。 なお、本発明におけるアミド化合物の毒性
は、例えば、サンショウ属植物が民間薬的にあるいは食
品として常用されていること、などにより一般に低毒性
である。
Chestnut Rat: The amide compound of the present invention itself or mixed with appropriate formulation excipients, binders, and diluents, and can be used as an ointment,
It can be administered orally or parenterally in the form of cream, liquid, capsule, syrup, injection, etc. Other drugs may be mixed as needed. The dosage may be increased or decreased as appropriate depending on age, body weight, and symptoms.
(Refer to Publication No. 2003)) is usually 0-1 mg to 10 g of amide compound (in oil form) per day for adults.
The amount is about 0.5 mg to about 5 g, more preferably about 0.5 mg to 5 g. In addition, the toxicity of the amide compound in the present invention is generally low because, for example, plants of the genus Salmonella are commonly used in folk medicine or as food.

[実験例コ 1、アミド化合物の 1 孔開の果皮450gをクロロホルムにて室温で抽出し、
得られた抽出液を減圧濃縮し抽出物87gを得た。この
抽出物をシリカゲルによるカラムクロマトグラフィー[
展開溶媒:クロロホルム−メタノール(30:1)]に
付し、5画分を得た。画分3(13,48)につきさら
にシリカゲルカラムクロマトグラフィー[展開溶媒:ベ
ンゼン−アセトン(17:3) ] を行ない、3両分
を得た。両分3−2(6,43g)につき、TSK g
el 0DS120T[東洋曹達工業(株)]による高
速液体クロマトグラフィー(展開溶媒:50%アセトニ
トリル)を行ない、7分画を得た。溶媒留去後、画分3
−2−1よりhydroxy−a−sanshoolと
hydroxy−β−5anshoo lの混合物(収
率:0.45% ) 、画分3−2−2よりhydro
xy−y −5anshool (収率:0.13χ)
、画分3−2=5より化合物I(収率:0.016%)
、画分3−2−6より化合物II (収率:0.008
%)、画分3−2−4より化合物III (収率:0.
013%)をそれぞれ得たく第1図参照)。
[Experiment Example 1, amide compound 1 Extract 450 g of pericarp with pores with chloroform at room temperature,
The obtained extract was concentrated under reduced pressure to obtain 87 g of extract. This extract was subjected to column chromatography using silica gel [
Developing solvent: chloroform-methanol (30:1)] to obtain 5 fractions. Fraction 3 (13,48) was further subjected to silica gel column chromatography [developing solvent: benzene-acetone (17:3)] to obtain three fractions. TSK g for both 3-2 (6,43g)
High performance liquid chromatography (developing solvent: 50% acetonitrile) was performed using el 0DS120T [Toyo Soda Kogyo Co., Ltd.], and 7 fractions were obtained. After solvent distillation, fraction 3
A mixture of hydroxy-a-sanshool and hydroxy-β-5anshool (yield: 0.45%) was obtained from fraction 3-2-1, and hydro
xy-y -5anshool (yield: 0.13χ)
, Compound I from fraction 3-2=5 (yield: 0.016%)
, compound II from fraction 3-2-6 (yield: 0.008
%), compound III from fraction 3-2-4 (yield: 0.
013%) (see Figure 1).

化合物■および化合物!■は高分解マススペクトルより
C18H29N 02 (化合物■、実測値:291.
219理論値:291.220化合物II+実測値:2
91.219理論値:291.220)がともに与えら
れる。化合物1および化合物IIのEI−MSスペクト
ルは極めて類似しており、以下のM+および一連のフラ
グメントイオンを示す。
Compound ■ and compound! ■ is C18H29N 02 (compound ■, actual value: 291.
219 Theoretical value: 291.220 Compound II + Actual value: 2
91.219 theoretical value: 291.220) are both given. The EI-MS spectra of Compound 1 and Compound II are very similar, showing the following M+ and a series of fragment ions.

m/z 291:(M”) 273:(「−H2O) 258: (M”−H2O−CH3) 244:(M”−)120−(CH3−CH2−))2
33:(M”−H2O−3XCH3)218: (M”
−H2O−(CI(3−CH2−CH=CH−))21
8: (M”−H2O−(CH3−CH2−CH=CH
−))204 : (M”−H2O−(CH3−CH2
−CH=CH−CH2−))203: (M”−(NH
−CH2−C(CH3) 2OH)]178: (M”
−H2O−(CH3−CH2−CH=CH−CH2−C
H=CH−) )164 : [M”−H2O−(CH
3−CH2−CH=CH−CH2−CI(=CH−CH
2−)] 150: (M”−H2O−(CH3−CH2−C)l
=CH−CH2−CH=CH−CH2−CH2−)] 124: (M”−H2O−(CH3−CH,、−CH
=CH−CH2−CH=CH−CH2−CH2−CH=
CH−)) 109:(CH3−(CH2−CH=CH) 2−CH
2)“93  :(M”−H2O−(CH3−(CH2
−CH=CH)2−CH2−CH2−(CH=CH) 
2)) また、化合物Iおよび化合物1■のIHNMR(表−1
)および13CNMR(表−2)スペクトルより化合物
Iおよび化合物nは CH3−(CHz−CH:CH) 2−CH2−CH2
−(CH”CH) 2CO−NH−CH2−(1:(C
H3)2OH(A) の構造式で示される幾何異性体と推定された。
m/z 291: (M”) 273: (“-H2O) 258: (M”-H2O-CH3) 244: (M”-)120-(CH3-CH2-))2
33: (M”-H2O-3XCH3) 218: (M”
-H2O-(CI(3-CH2-CH=CH-))21
8: (M”-H2O-(CH3-CH2-CH=CH
-))204: (M”-H2O-(CH3-CH2
-CH=CH-CH2-))203: (M”-(NH
-CH2-C(CH3) 2OH)]178: (M”
-H2O-(CH3-CH2-CH=CH-CH2-C
H=CH-))164: [M”-H2O-(CH
3-CH2-CH=CH-CH2-CI(=CH-CH
2-)] 150: (M”-H2O-(CH3-CH2-C)l
=CH-CH2-CH=CH-CH2-CH2-)] 124: (M"-H2O-(CH3-CH,, -CH
=CH-CH2-CH=CH-CH2-CH2-CH=
CH-)) 109: (CH3-(CH2-CH=CH) 2-CH
2) “93:(M”-H2O-(CH3-(CH2
-CH=CH)2-CH2-CH2-(CH=CH)
2)) In addition, IHNMR of Compound I and Compound 1■ (Table 1
) and 13CNMR (Table 2) spectrum, Compound I and Compound n are CH3-(CHz-CH:CH) 2-CH2-CH2
-(CH”CH) 2CO-NH-CH2-(1:(C
It was presumed to be a geometric isomer represented by the structural formula H3)2OH(A).

化合物■および化合物IIの13CNMRスペクトルを
化合物III及びその幾何異性体hydroxy−γ−
5anshoo Iの” CNMRスペクトル、さらに
Haanらによる幾何異性体に於ける1 3CNMR化
学シフトのしゃへい効果の考察(Organic Ma
gnetic Re5onance。
The 13C NMR spectra of Compound Ⅰ and Compound II were compared to Compound III and its geometric isomer hydroxy-γ-
5anshoo I” CNMR spectrum, and consideration of the shielding effect of 13C NMR chemical shift in geometric isomers by Haan et al. (Organic Ma
gnetic Re5onance.

互(3)、 147 (1973) ]について検討し
、化合物lおよび化合物I■の13CNMRシグナルを
表−2に示すように帰属した。
(3), 147 (1973)], and assigned the 13C NMR signals of Compound I and Compound I as shown in Table 2.

以上より、化合物■および化合物nは骨格(A)の11
.12位の二重結合に基づく幾何異性体であり、化合物
Iは(2E、4E、82,112)−2°−1sobu
tyl−2、4,8,11−tetradeeatet
raenamlde、化合物I!は(2E、4E、8Z
、IIE)−2°−1sobutyl−2,4,8,1
1−tetradecatetraenamideと決
定した。
From the above, compound ■ and compound n are 11 of skeleton (A).
.. It is a geometric isomer based on the double bond at position 12, and compound I is (2E, 4E, 82,112)-2°-1sobu
tyl-2,4,8,11-tetradeatet
raenamlde, compound I! is (2E, 4E, 8Z
, IIE)-2°-1sobutyl-2,4,8,1
It was determined to be 1-tetradecatetraenamide.

北J1姐世 化合物111は高分解能マススペクトルより組成式とし
てCIBH27HO□(実測値: 289.204  
理論値:289.204)が与えられる。EI−MSス
ペクトルは、以下に示したM+及び一連のフラグメント
イオンを与える。
The compositional formula of Kita J1 Aisei Compound 111 is CIBH27HO□ (actual value: 289.204) from high-resolution mass spectra.
Theoretical value: 289.204) is given. The EI-MS spectrum gives the M+ and series of fragment ions shown below.

化合物のE I −MS m/z  289:(M”) 271 : [M”−H20] 258: (M”−H2O−CH3) 231 : (M”−H2O−3XCH3)230: 
(M”−H2O−(CH3−CH=CH−))204 
: (M”−H2O−(CH3−CH=CH−CH=C
H−) )201 : (M”−H2O−(NH−CH
”C(CH3)2))164: (M”−H2O−((
:H3−(CH=CH)3−CH2−))150: (
M”−H2O−(CH3−(CH=CH) 3−CH2
−CH2−) )124 : (M”−H2O−(CH
3−(CH=CH) 3−CH2−CH2−CH=CH
−)) 107: (CH3−(CH=CH)3−C12)”6
7  :(CI、(CH=CH)2)”又、化合物(F
)IHNMR(表−1’) 及(F13CNMR(表−
2)スペクトルより、化合物IIIはhydroxy−
γ−5anshoolの幾何異性体であると推定された
。化合物IIIはhydroxy−y−sanshoo
lとの13CNMRXベクトルの比較より、1本のメチ
レン及びメチンのシグナルが異なる。これは、表2に示
したhydroxy−α−5anshool(62)及
びhydroxy−β−5anshoo 1 (6E)
のC−5,8位の炭素シグナルに認められる幾何異性体
に基づく化学シフトと良く一致する。
E I -MS of compound m/z 289: (M”) 271: [M”-H20] 258: (M”-H2O-CH3) 231: (M”-H2O-3XCH3) 230:
(M”-H2O-(CH3-CH=CH-))204
: (M”-H2O-(CH3-CH=CH-CH=C
H-))201: (M”-H2O-(NH-CH
“C(CH3)2))164: (M”-H2O-((
:H3-(CH=CH)3-CH2-))150: (
M”-H2O-(CH3-(CH=CH) 3-CH2
-CH2-) )124 : (M”-H2O-(CH
3-(CH=CH) 3-CH2-CH2-CH=CH
-)) 107: (CH3-(CH=CH)3-C12)”6
7: (CI, (CH=CH)2)"Also, compound (F
) IHNMR (Table-1') and (F13CNMR (Table-1')
2) From the spectrum, compound III is hydroxy-
It was presumed to be a geometric isomer of γ-5anshool. Compound III is hydroxy-y-sanshoo
Comparison of the 13CNMRX vector with 1 shows that the signals of one methylene and methine are different. This is hydroxy-α-5anshoo (62) and hydroxy-β-5anshoo 1 (6E) shown in Table 2.
It agrees well with the chemical shift based on the geometric isomer observed in the carbon signals at the C-5 and C-8 positions.

以上より、化合物IIIはhydroxy−7−5an
shoo Iの8.9位の二重結合に基づく幾何異性体
(2E、4E。
From the above, compound III is hydroxy-7-5an
Geometric isomers based on the double bond at position 8.9 of shoo I (2E, 4E).

8E、 IOE、 12E)−2°−hydroxyl
−N−!5obutyl−2,4.8.10゜12−t
etradeeapentaenamideと決定した
8E, IOE, 12E) -2°-hydroxyl
-N-! 5obutyl-2, 4.8.10゜12-t
It was determined to be ettradeeapentaenamide.

叉員勇 成人男子(25才〜42才)6名および成人女子(22
才〜26才)4名を選び、上記実験例で調整した化合物
610n+gを直接舌に塗布し麻酔効果を判定した。
6 adult males (25-42 years old) and 6 adult females (22 years old)
Compound 610n+g prepared in the above experimental example was applied directly to the tongues of four subjects (aged 26 to 26 years old) to determine the anesthetic effect.

ヌjlL果 いずれの化合物も30秒以内に麻痺効果が現われ、20
〜80分間持続的であった。
Both compounds have a paralyzing effect within 30 seconds, and 20
Lasted for ~80 minutes.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図はアミド化合物の分離図を示す。 特許出願人  湧永製薬株式会社 U)的 FIG. 1 shows a separation diagram of an amide compound. Patent applicant: Yukinaga Pharmaceutical Co., Ltd. U) target

Claims (1)

【特許請求の範囲】 1、下式で示されるアミド化合物 CH_3CH_2CH=CHCH_2CH=CH−CH
_2CH_2CH=CHCH=CHCONH−CH_2
C(CH_3)_2OH 2、サンショウ属(Zanthoxylum)植物より
取得すること、を特徴とする下式で示されるアミド化合
物の製造法 CH_3CH_2CH=CHCH_2CH=CH−CH
_2CH_2CH=CHCH=CHCONH−CH_2
C(CH_3)_2OH 3、サンシヨウ属(Zanthoxylum)植物が花
椒〔Zanthoxylum bungeanum M
axim.〕である特許請求の範囲第2項記載の製造法
[Claims] 1. An amide compound represented by the following formula CH_3CH_2CH=CHCH_2CH=CH-CH
_2CH_2CH=CHCH=CHCONH-CH_2
A method for producing an amide compound represented by the following formula, characterized in that C(CH_3)_2OH 2 is obtained from a plant of the genus Zanthoxylum CH_3CH_2CH=CHCH_2CH=CH-CH
_2CH_2CH=CHCH=CHCONH-CH_2
C(CH_3)_2OH 3, Plants of the genus Zanthoxylum are called pepper [Zanthoxylum bungeanum M
axim. ] The manufacturing method according to claim 2, which is
JP62329012A 1987-12-24 1987-12-24 Novel amide compound and production thereof Pending JPH01294657A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62329012A JPH01294657A (en) 1987-12-24 1987-12-24 Novel amide compound and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62329012A JPH01294657A (en) 1987-12-24 1987-12-24 Novel amide compound and production thereof

Publications (1)

Publication Number Publication Date
JPH01294657A true JPH01294657A (en) 1989-11-28

Family

ID=18216612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62329012A Pending JPH01294657A (en) 1987-12-24 1987-12-24 Novel amide compound and production thereof

Country Status (1)

Country Link
JP (1) JPH01294657A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000002570A1 (en) * 1998-07-07 2000-01-20 Indena S.P.A. Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them
KR100379984B1 (en) * 2000-05-24 2003-04-16 씨제이 주식회사 Composition for whitening of skin and suppressing of aging containing extract of Zanthoxylum piperitum seed coat
WO2010094477A2 (en) 2009-02-23 2010-08-26 Indena S.P.A. Cosmetic wrinkel treatment method based on zanthoxylum bungeanum extract
WO2012073910A1 (en) * 2010-11-30 2012-06-07 株式会社ツムラ Method for producing sanshool
CN103099163A (en) * 2011-11-14 2013-05-15 长谷川香料株式会社 Manufacture method for extract comprising hydroxy sanshool
CN109627353A (en) * 2018-12-20 2019-04-16 四川大学 A kind of method of water-soluble polysaccharide and spicy components in extraction zanthoxylum slag

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000002570A1 (en) * 1998-07-07 2000-01-20 Indena S.P.A. Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them
AU749947B2 (en) * 1998-07-07 2002-07-04 Indena S.P.A. Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them
US6419950B2 (en) 1998-07-07 2002-07-16 Indena Spa Extracts of zanthoxylum bungeanum, and pharmaceutical and cosmetic formulations containing same
KR100379984B1 (en) * 2000-05-24 2003-04-16 씨제이 주식회사 Composition for whitening of skin and suppressing of aging containing extract of Zanthoxylum piperitum seed coat
WO2010094477A2 (en) 2009-02-23 2010-08-26 Indena S.P.A. Cosmetic wrinkel treatment method based on zanthoxylum bungeanum extract
WO2012073910A1 (en) * 2010-11-30 2012-06-07 株式会社ツムラ Method for producing sanshool
CN103249714A (en) * 2010-11-30 2013-08-14 株式会社津村 Method for producing sanshool
US8871962B2 (en) 2010-11-30 2014-10-28 Tsumura & Co. Method for producing sanshool
JP5648693B2 (en) * 2010-11-30 2015-01-07 株式会社ツムラ Manufacturing method of sunsholes
TWI486353B (en) * 2010-11-30 2015-06-01 Tsumura & Co Production methods of sanshool
CN103099163A (en) * 2011-11-14 2013-05-15 长谷川香料株式会社 Manufacture method for extract comprising hydroxy sanshool
CN109627353A (en) * 2018-12-20 2019-04-16 四川大学 A kind of method of water-soluble polysaccharide and spicy components in extraction zanthoxylum slag

Similar Documents

Publication Publication Date Title
Jolad et al. Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production
AU5561490A (en) New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
Zhi‐Hui et al. Albaconol, A Novel Prenylated Resorcinol (= Benzene‐1, 3‐diol) from Basidiomycetes Albatrellus confluens
SK9498A3 (en) Use of calendula glycosides for the treatment of psoriasis
Loyola et al. Diterpenoids from Azorella compacta
Spencer et al. Alkyl and phenylalkyl anacardic acids from Knema elegans seed oil
US4046914A (en) Therapeutically active substituted saturated and mono-and polyunsaturated alkyl-glycerylethers
Gotta et al. On the active principles of the Euphorbiaceae, IXa ingenane type diterpene esters from five Euphorbia species
Brooks et al. Daphnane diterpenes of Thymelaea hirsuta
JPH01294657A (en) Novel amide compound and production thereof
Siddiqui et al. Chemical constituents of the flowers of Azadirachta indica
Zalkow et al. The lower terpenoids of Isocoma wrightii
Vigor et al. Three clerodane diterpenoids from Croton eluteria Bennett
Abreu et al. Volatile Constituents of the Rhizomes of Aframomum alboviolaceum (Ridley) K. Schum. from Guinea‐Bissau
Fullas et al. Gummiferol, a cytotoxic polyacetylene from the leaves of Adenia gummifera
Ruangrungsi et al. Constituents of Paramichelia baillonii: a new antitumor germacranolide alkaloid
KR100627933B1 (en) Hyperforin derivatives, the use thereof and formulations containing them
Rizk et al. Irritant resiniferonol derivatives from Egyptian Thymelaea hirsuta L.
JP2005179339A (en) New compound and medicinal composition
US20060205808A1 (en) Anti-inflammatory and cure for ageing, Alzheimer&#39;s disease on phloroglucinol derivatives
KR100809731B1 (en) Pharmaceutical composition comprising --secoisolariciresinol
WO2001090064A2 (en) COMPOSITION AND METHOD CONTAINING PRODUCTS EXTRACTED FROM COMMIPHORA Sp. FOR PREVENTION AND TREATMENT OF ABNORMAL CELL GROWTH AND PROLIFERATION IN INFLAMMATION, NEOPLASIA AND CARDIOVASCULAR DISEASE
Karalai et al. Medicinal plants of euphorbiaceae occurring and utilized in thailand. V. Skin irritants of the daphnane and tigliane type in latex of Excoecaria bicolor and the uterotonic activity of the leaves of the tree
Ali et al. Some chemical constituents from marine algae of Karachi coast (Arabian Sea)
de Lima Guimarães et al. Structural Elucidation of a New Sesquiterpene Alcohol by Comparative NMR Studies.